Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (131-140 of 610) with videos related to

Pageof 61
Sort By:
Respiratory Research|January 27, 2016
Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cellsSeamus Grundy, Jonathan Plumb, Manminder Kaur, et al.
Lancet (London, England)|October 11, 2018
Inhaled triple therapy in chronic obstructive pulmonary disease - Authors' replyAlberto Papi, Dave Singh, Stefano Petruzzelli, et al.
Respirology (Carlton, Vic.)|April 9, 2009
Reduced exhaled breath condensate pH in asthmatic smokers using inhaled corticosteroidsBinita Kane, Zoe Borrill, Thomas Southworth, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 6, 2017
Clinical characteristics of COPD patients with tidal expiratory flow limitationJames Dean, Umme Kolsum, Paul Hitchen, et al.
Archivos De Bronconeumologia|August 20, 2025
Biological Therapy in COPD Management: Current Evidence, Challenges and OpportunitiesDave Singh, Antonio Menéndez Lobo, Andrew Higham, et al.
ERJ Open Research|March 11, 2026
Increased alveolar tissue destruction in a sub-group of COPD patients with increased alveolar septal eosinophil countsAndrew Higham, Sophie Booth, Josiah Dungwa, et al.
NPJ Primary Care Respiratory Medicine|June 17, 2016
Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary diseaseDave Singh, Massimo Corradi, Monica Spinola, et al.
Current Opinion in Pulmonary Medicine|November 6, 2019
Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinicianDave Singh, Gabriella Long, José E D Cançado, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 28, 2020
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed AnalysisHenrik Watz, Kathleen Rickard, Tara Rheault, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2019
Reply to Pouwels <i>et al.</i>: Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary DiseaseRobert A Stockley, David Halpin, Bartolome R Celli, et al.
Pageof 61

Showing results (131-140 of 610) with videos related to

Sort By:
Pageof 61
Respiratory Research|January 27, 2016
Additive anti-inflammatory effects of corticosteroids and phosphodiesterase-4 inhibitors in COPD CD8 cellsSeamus Grundy, Jonathan Plumb, Manminder Kaur, et al.
Lancet (London, England)|October 11, 2018
Inhaled triple therapy in chronic obstructive pulmonary disease - Authors' replyAlberto Papi, Dave Singh, Stefano Petruzzelli, et al.
Respirology (Carlton, Vic.)|April 9, 2009
Reduced exhaled breath condensate pH in asthmatic smokers using inhaled corticosteroidsBinita Kane, Zoe Borrill, Thomas Southworth, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 6, 2017
Clinical characteristics of COPD patients with tidal expiratory flow limitationJames Dean, Umme Kolsum, Paul Hitchen, et al.
Archivos De Bronconeumologia|August 20, 2025
Biological Therapy in COPD Management: Current Evidence, Challenges and OpportunitiesDave Singh, Antonio Menéndez Lobo, Andrew Higham, et al.
ERJ Open Research|March 11, 2026
Increased alveolar tissue destruction in a sub-group of COPD patients with increased alveolar septal eosinophil countsAndrew Higham, Sophie Booth, Josiah Dungwa, et al.
NPJ Primary Care Respiratory Medicine|June 17, 2016
Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary diseaseDave Singh, Massimo Corradi, Monica Spinola, et al.
Current Opinion in Pulmonary Medicine|November 6, 2019
Small airway disease in chronic obstructive pulmonary disease: insights and implications for the clinicianDave Singh, Gabriella Long, José E D Cançado, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 28, 2020
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed AnalysisHenrik Watz, Kathleen Rickard, Tara Rheault, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2019
Reply to Pouwels <i>et al.</i>: Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary DiseaseRobert A Stockley, David Halpin, Bartolome R Celli, et al.
Pageof 61